Please try another search
As of February 2, 2024, Cuspis Capital III Ltd. was acquired by Cytophage Technologies Inc., in a reverse merger transaction. Cuspis Capital III Ltd. does not have significant operations. It intends to identify, evaluate, and acquire assets or businesses with a view to complete a qualifying transaction. The company was incorporated in 2019 and is headquartered in Toronto, Canada.
Name | Age | Since | Title |
---|---|---|---|
Michael D. Cochrane | - | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review